BioCryst Pharmaceuticals, Inc. announced the appointment of Anthony Doyle as senior vice president and chief financial officer (CFO). Prior to this role, Doyle was working with Worldwide Clinical Trials, a full-service global contract research organization, where he has served as CFO since 2014. From 2004 to 2012, Doyle held a series of increasingly responsible roles…